Drug delivery to macrophages for the therapy of cancer and infectious diseases.

about

Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy.Synergistic effect of phospholipid-based liposomes and propylthiouracil on U-937 cell growth.Receptor mediated glycotargeting.Liposome uptake by human retinal pigment epithelial cells in culture.

P2860

Q37883474-6A07B399-226A-473F-A15E-BF6D0461E5BC Q40333885-FD2CB85C-CEA8-468A-A239-A5D56563687C Q40381389-98CAE02E-1E15-41AE-BE19-AAC560CA2D36 Q50526336-6D7FA120-5405-455D-90D1-172E50B5E50D

P2860

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

Item

http://www.wikidata.org/entity/Q39696541

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年学术文章

@wuu

1987年学术文章

@zh-cn

1987年学术文章

@zh-hans

1987年学术文章

@zh-my

1987年学术文章

@zh-sg

1987年學術文章

@yue

1987年學術文章

@zh

1987年學術文章

@zh-hant

name

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@en

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@nl

type

Item

label

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@en

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@nl

prefLabel

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@en

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@nl

P1476

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

@en

P2093

Bugelski PJ

http://www.w3.org/2001/XMLSchema#string

Kirsh R

http://www.w3.org/2001/XMLSchema#string

Poste G

http://www.w3.org/2001/XMLSchema#string

P2860

Enhanced efficacy of liposome-encapsulated ribavirin against Rift Valley fever virus infection in mice

Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.

Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.

Macrophage activation: priming activity from a T-cell hybridoma is attributable to interferon-gamma.

Cell surface receptors for lymphokines. I. The possible role of glycolipids as receptors for macrophage migration inhibitory factor (MIF) and macrophage activation factor (MAF).

Lipoproteins as potential site-specific delivery systems for diagnostic and therapeutic agents.

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

Synthetic immunostimulants derived from the bacterial cell wall.

Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study.

P304

141-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1987.TB45797.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

507

http://www.w3.org/2001/XMLSchema#string

P577

1987-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3327409

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

about

P2860

P2860

Drug delivery to macrophages for the therapy of cancer and infectious diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P921